Avapritinib in Patients With Advanced Systemic Mastocytosis (AdvSM): Efficacy and Safety Analysis From the Phase 2 PATHFINDER Study With 3-Year Follow-up
Year: 2024
Type: article
Authors: Andreas Reiter, Jason Gotlib, Deepti H. Radia, Iván Alvarez-Twose, Michael W. Deininger, Tracy I. George, Jens Panse, Kristen M. Pettit, Alessandro M. Vannucchi, Uwe Platzbecker, Olivier Hermine, Amro Elshoury, Christina Bulai Livideanu, Ruben Mesa, Celalettin Ustun, Massimo Triggiani, Ingunn Dybedal, Joseph Jurcic, Roberta Zanotti, Lambert F. Span, Stephen T. Oh, Abdulraheem Yacoub, Elizabeth O. Hexner, Prithviraj Bose, Stephanie Lee, Wolfgang R. Sperr, Elizabeth A. Griffiths, Matthew Butler, Ilda Bidollari, Hui-Min Lin, Svetlana Rylova, Javier I. Muñoz-González, Daniel J. DeAngelo
Language: English
Topic: Mast cells and histamine
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4401896974